Evidence map›Paper›PMID 41303316›Full record

ReviewInternational journal of molecular sciences2025

Hydrogel Design Based on Bacterial Exopolysaccharides: The Biomedical Promise of Levan.

Andrada Ioana Popa, Rahela Carpa, Anca Farkas

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Andrada Ioana PopaDepartment of Molecular Biology and Biotechnology, Faculty of Biology and Geology, Babeș-Bolyai University, 1 M. Kogălniceanu Street, 400084 Cluj-Napoca, Romania.ORCID 0009-0002-1867-5121
Rahela CarpaDepartment of Molecular Biology and Biotechnology, Faculty of Biology and Geology, Babeș-Bolyai University, 1 M. Kogălniceanu Street, 400084 Cluj-Napoca, Romania.ORCID 0000-0001-8974-1718
Anca FarkasDepartment of Molecular Biology and Biotechnology, Faculty of Biology and Geology, Babeș-Bolyai University, 1 M. Kogălniceanu Street, 400084 Cluj-Napoca, Romania.ORCID 0000-0003-0985-1461

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial exopolysaccharides have emerged as versatile biopolymers for the design of advanced hydrogels with adjustable physico-chemical, mechanical, and biological properties. Among these, levan, a fructose-based exopolysaccharide synthesized by various microbial species, has attracted increasing attention due to its unique structural features, high biocompatibility, and inherent bioactivity. This review provides a comprehensive overview of hydrogel systems derived from bacterial exopolysaccharides, with a particular focus on levan-based hydrogels. We discuss the molecular structure, synthesis pathways, and physico-chemical characteristics of levan that underpin its hydrogel-forming ability. Emphasis is placed on design strategies, including chemical modification, crosslinking approaches, and composite formation, that enable fine-tuning of mechanical strength, swelling behavior, and degradation kinetics. This review further highlights biomedical applications of levan-based hydrogels, encompassing drug delivery, wound healing, rejuvenation, tissue engineering, regenerative medicine, and bioprinting, while addressing current limitations and future research directions. By elucidating the structure-function relationships and emerging fabrication methodologies, this review underscores the biomedical promise of levan as a sustainable and functional biopolymer for next-generation hydrogel technologies.

Indexed as

BacteriaFructansHydrogelsPolysaccharides, BacterialAnimalsBiocompatible MaterialsDrug Delivery SystemsHumansTissue EngineeringBiocompatible MaterialsFructansHydrogelslevanPolysaccharides, Bacterialbacterial exopolysaccharidesbiomedical applicationshydrophilic gelslevan

Identifiers

PMID41303316
PMCPMC12652085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.